Related Experiment Video
Updated: Jun 8, 2026
10:32
Transvaginal Mesh Insertion in the Ovine Model
Published on: July 27, 2017
Contraceptive vaginal rings: a review.
Vivian Brache1, Anibal Faundes
1PROFAMILIA, P.O. Box 1053, Santo Domingo 10401, Dominican Republic. biomedica@codetel.net.do
Contraception
|October 12, 2010
Summary
Contraceptive vaginal rings (CVRs) offer a safe and effective hormonal birth control option. These rings provide user control and consistent hormone release, expanding contraceptive choices for women.
Area of Science:
- Reproductive Health
- Pharmacology
- Biomaterials Science
Background:
- Development of contraceptive vaginal rings (CVRs) leverages vaginal steroid absorption and elastomer-based controlled release.
- Over 40 years of research have led to CVRs like NuvaRing (etonogestrel/ethinylestradiol) and Progering (progesterone).
Observation:
- CVRs demonstrate high contraceptive effectiveness, comparable or superior to oral contraceptives.
- Advantages include ease of use, user-initiated control, consistent low-dose hormone release, and good cycle control.
- Disadvantages involve potential vaginal discharge, expulsion, and user discomfort during intercourse or insertion.
Findings:
- Clinical studies confirm that CVRs are safe, effective, and highly acceptable to users.
- The nearly constant release rate contributes to enhanced bioavailability and reduced hormonal dose.
Implications:
- CVRs represent a significant advancement in hormonal contraception, offering women a reliable alternative.
- Expanding the range of available contraceptive methods empowers women with greater reproductive autonomy.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...